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Increasing prevalence of Aspergillus Fumigatus in patients with CF 
R. Ujhelyi 1, G. Kat ona l, L. Kovfics ~, K. Holics l
~Heim PdI Hospital for ChiMre~ 2Semmelweis University, Budapest, Hungary 
Aspergillus fumigatus (AF) is found frequently ha the sputum culture of patients 
with CF (5 50%). ha the past decades ha our CF Centre (104 children mad young 
adult), AF was a rarity. In 2004 year, we detect more AF. We could detect AF 
colonies in sputum culture of 8 patients, age 12 24 year (mean:14,7). All, except 
one, patients were colonized with Pseudomonas aeruginosa. Seven had normal 
serum total IgE, normal eosinophil count, negative serum antibodies against AE 
The eights patient, a 12 year old girl (homozygous DF508), arrived home for 
summer vacation from Malaysia. (ha the regular assessment, wi hout any serious 
respiratory symptoms, we establish atotal left lung atelect asis. HRCq" showed mild 
periferial bronchiectasis, a plug alter the bifurcation of the main bronchi, making 
atelect asis of the total left lung. She had no wheezing, LFI" was worse, than a year 
before (FEV1 71%vs 77 %). We performed a bronchoscopy and lavage, but we 
could not sucked out the rigid elastic, white mass. During the unsuccessful 
antibiotic therapy, we got AF from the bronchial avage culture, serum total IgE 
1648 U/mL, eosinophil count 9CO)/mm ~, mad serum antibodies against AF were 
detected. We valued this disease to an ABPA, and treated with steroid and 
itr aconazole. The atelectasis disappeared alter seven week steroid mad itraconazole 
therapy, serum IgE normalized. However, tapering the steroid dose, the IgE 
increased again, without clinical worsening. Conclusion: The increasing prevalence 
of AF may have many reasons: the more accurate culture of the sputum, the more 
aggressive antibiotic treatment orthe spreading of the air condition in Hungary. Our 
only case with ABPA is probably due to the climatic circumstances of Kuala 
Lumpur. 
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Recombinant Aspergillus allergens for diagnosis of ABPA in CF and 
non-CF paSents 
M. Mir zoyml l, J. Gahr l, S. Salvenmoser l, M. WiebeF, F. M. Mfiller l 
iPediatric PuImonology, Cystic Fibrosis Centre and Infectious Diseases, 
Department of Pediatrics III, University Heidelberg, INF I53, 2Thoraxklinik ant 
Universi~tsklinikum Heidelberg, Heidelberg, Germany 
Aims: The diaguosis of ABPA is often difficult ha patients with sensitization to A. 
fumigatus. The aim of the study was to assess rasp allergens together with other 
criteria of ABPA in CF and non CF patients. 
Methods: A total of CF (n 38) mad non CF (n 69) patients were enrolled in this 
prospective study from the CF Centre Heidelberg. Initially total IgE levels and rasp 
f l ,  f2, 13, f4, and f6 were measured by UniCAP 10[) (PHARMACIADiagnostics) 
using ImmunoCAP solid phase technology. According to the responses the patients 
were grouped as rasp+ (RAST class >2) and rasp . The rasp+ patients' age, sex, 
eosinophils, sputum color, At" in sputum, total IgE, SPT Af, IgElIgG to Af  and chest 
X~ay/Cq'/MRI were investigated. 
Results: O1" the 107 patients 18 demonstrated + and 89 responses to the five rAsp 
antigens. The rasp+ group was divided in CF (n 15) and non CF (n 3). 10 CF mad 
2 non CF patients fulfilled at least 3 of 5 criteria of recommendations for diaguosis 
for ABPA in CF [1]. The patients demonstrated total IgE level >500 kU/mL, +SPT, 
elevated IgE/IgG to Af  and abnormalities on chest X ray/CT. The results 
demonstrate hat rAsp f l  are recoguised by sera of 8/2,1"2 by 10/1,13 by 5/1, f4 by 
5/1, and f6 by sera of 3/1 of CF/non CF patients, ha contrast, patients that didn't 
fulfil the criteria rAsp fl  was + in 3/1, 1"2 in 4/0, 13 in 3/0, f4 in 1/0, mad f6 ha 0/0 
CF/non CF patients. 
Conclusion: This study demonstrates that rasp H, 1"2 mad 13 elicit IgE responses in 
patients with ABPA as well as with sensitization toAf, whereas rAsp f4 mad f6 only 
in patients fulfilling criteria for ABPA. 
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The importance of histopathologic findings in the diagnosis of 
Aspergillus fumigatus infection in CF 
E. De Wachter 1, A. Malt¥oot 1, D. Pierard 9, A. Goossens ~ 
~CF Center; 2Department of Microbiology, 3Department of Pathology AZ-VUB- 
Brussels, Belgium 
Although sputum cultures in CF patients otlen show the presence of Aspergillus 
fumigatus (AF), the absence of this fungus doesn't exclude colonization or 
infection. Hist opathologic signs, like the presence of hyphae, play an additive role 
ha the diagnosis of AF infection. Allergic responses to AF are well described 
(ABPA), but invasive disease is very rare in CF. Case report: A 25 yrs old CF patient 
presents with fever and dyspnea. Sputum cultures remain egative for AF and only 
show the presence of Pseudomonas aeruginosa. She did have positive fungal 
cultures in the past, treated with itraconazole. Unless administration of 
pseudomonas sensitive antibiotics, she deteriorates rapidly. Because of persistent 
wheezing, eosinophilia mad positive precipitins, ABPA is suspected. Cot ticoster oids 
and itraconazole are added. Twelve days later chest X ray showes diffuse nodular 
infiltrates. Although negative fungal cultures, hislopathologic sputum analysis 
show huge amounts of characteristic hyphae for AF, and invasive aspergillosis is 
suspected. Voriconazole is added, while cot ticoster oids are interrupted. Unless these 
measures the patient dies 2 days later. Conclusion: I f  an uncommon i fection in CF 
is suspected, sputum samples hould be examined by histopathologic techniques 
next to the commonly used micr obiologic techniques. 
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Long-term adrenal insufficiency after keatment with ikaconazole and 
budesonide in CF paSents with ABPA: A 5-year follow-up 
M. Skov, T. Pressler 
Cystic Fibrosis Center; Copenhagen, De~rtark 
Aims Itraconazole inhibition of CYP3A may interfere with adrenal s~er oidogenesis 
and metabolism of budesonide. We have previously found adrenal insufficiency as 
a side effect ha cystic fibrosis (CF) patients with allergic bronchopulmonary 
aspergillosis (ABPA) treated with itraconazole in combination with budesonide. 
The present study is a 5 year follow up of adrenal function in these patients. 
Methods CF patients with ABPA, who developed adrenal insufficiency after 
combination therapy were included. They were treated with itr aconazole for ABPA 
(4CO 600 rag/day) and budesonide as anti ilfflammatory agent (800 1600 ~tg/day). 
Alter withdrawal of itraconazole and budesonide hydrc¢ortisone substitution 
therapy (10 mghng/day) was started in patients not receiving pre&aisolone. P AC1TI 
and stimulated (250 pg tetracosactid v) p~cortisol were measured. Results Heven 
of 25 (44%) patients had adrenal insufficiency. Median accumulated itraconazole 
dose was 420 g (3 788 ); median duration of treatment 55 months (1 100). P AC1TI 
levels normalized within the 1st year after withdrawal. One patient regained adrenal 
function within the 1st year, one in the 2nd year and two ha the 5th year. Tbree 
patients were not re tested due to pre&aisolone treatment (>5 mg/day). In the 
remaining 4 patients maximum stimulated p~cortisol evels were 55 213, 174 346, 
182 373, 178 336 nmol/L after 1, 2, 3 mad 4 years, respectively. Adrenal 
insufficiency was unrelated to dose and duration of treatment. Conclusions Within 
the 5 year period 1/3 of the patients did not recover, 1/3 slowly regained adrenal 
function and 1/3 stayed on pre&aisolone treatment to control ABPA. Adrenal 
suppression, irrespective of the duration, may last for years. Monitoring of adrenal 
function during and after withdrawal of treatment is crucial. 
